BICARA THERAPEUTICS INC (BCAX) Stock Analyst Ratings
NASDAQ:BCAX - Nasdaq - US0554771032 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to BCAX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.86. This target is 265.31% above the current price.
BCAX was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about BCAX.
In the previous month the buy percentage consensus was at a similar level.
BCAX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-23 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2025-05-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-17 | Wells Fargo | Initiate | Underweight |
| 2025-04-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-02-06 | Wedbush | Initiate | Outperform |
| 2025-01-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-06 | HC Wainwright & Co. | Initiate | Buy |
| 2024-10-08 | TD Cowen | Initiate | Buy |
| 2024-10-08 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-10-08 | Stifel | Initiate | Buy |
| 2024-10-08 | Morgan Stanley | Initiate | Overweight |